SUMMARY Thirty patients with hepatic reactions to cyclofenil, a non-steroidal drug with a stimulating effect on ovulation, are reviewed. The liver damage was probably related to metabolic idiosyncrasy, and was reversible in all patients.
increased serum aminotransferases were observed for the first time after 10 weeks of treatment (Table) . The patient felt tired and experienced some pruritis, but was otherwise well and afebrile. There was no skin rash or lymphadenopathy, hepatomegaly, or splenomegaly.
A liver biosy, performed 10 days after discontinuation of cyclofenil showed a preserved lobular architecture, but some portal fibrosis and round cell infiltration. The limiting plate was destroyed, but there were no piecemeal necroses. Numerous acidophilic bodies were observed as well as ballooning and, around the central veins,
Received for publication 8 June 1982 hepatocytes with pyknosis and abundance of lipofuscin. Lymphocytes and histiocytes were seen in the vicinity of degenerated hepatocytes. Some Kupffer cell proliferation was also observed. There was no cholestasis or steatosis, and no granulomas.
A The daily dosage was not reported in three patients. It was 100 mg in three patients, 200 mg in 21, 300 mg in one, 400 mg in one, and 600 mg in one patient.
The duration of treatment before the appearance of symptoms of liver disease was less than one 260 ,ukat/l (normal c0*7 ,ukat/l). In 22/28 there was a predominance of S-ALAT over S-ASAT. There was no relation between the maximum ALAT value and the dosage of cyclofenil or the duration of treatment. The time for normalisation of liver tests after stopping the administration of cyclofenil was reported in only 12 patients, and was about four weeks in six, two months in four, and five months in one, whereas in one patient a normalisation had not yet occurred after four months.
A fine needle aspiration biopsy for cytological investigation was available in one patient, showing a slight cholestasis without liver cell necroses or inflammatory cells. A needle biopsy was available in six patients. These all showed lesions resembling viral hepatitis, with lymphohistiocytic portal tract inflammatory reaction as well as lobular changes consisting of ballooning of hepatocytes, hepatocellular necrosis, infiltration by lymphocytes and histiocytes, and Kupffer cell proliferation (Fig. 1) . In one patient, the liver biopsy also showed numerous small epithelioid cell granulomas with occasional giant cells and a few eosinophils. The granulomas were mostly seen near the portal tracts. Three biopsies displayed slight cholestasis with bile plugs in canaliculi. A striking observation was the increased amount of lipofuscin observed in five patients. The pigment occurred as fine granules in centrilobular hepatocytes (Fig. 2) , interstitially, or in phagocytes in portal tracts and Kupffer cells. Some heavily pigmented hepatocytes showed degenerative changes with lysis (Fig. 3) .
Discussion
In the present series of 30 patients, the long delay before signs of liver damage appeared, the lack of relation between maximum ALAT level and dosage of cyclofenil as well as the histological picture make a direct toxic effect improbable.
Eighty Cyclofenil is used not only in Sweden, but also in England, France, Italy, Japan, and Germany. It is, therefore, surprising that there are no reports of liver damage from these countries in view of the rather high incidence of reactions in our country. Based on a registered total sale of about 3-3 millions of 100 mg tablets during 1971-80 and a presumed average treatment amounting to two tablets daily for 90 days, the incidence of reported liver reactions in Sweden during the period can be estimated at 1.3%. As mentioned in the introduction, increased aminotransferase values have recently also been reported in a Swedish study of cyclofenil treatment in progressive systemic sclerosis. ' It may well be, therefore, that there is a geographic difference in susceptibility to the drug, such as has been observed for oestrogen-induced liver damage, which is more common in Scandinavia and Chile."
